IDEC-152

· Biogen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDEC-152, covering 2013-09-16 to 2013-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) [Phase 1]